Profile for BioXcel Therapeutics Inc. (BTAI)

$ 23.22   1.91 (+8.96%) Volume: 358.5k 4:00 PM EDT Apr 9, 2020
After Hours:  $ 23.22 0.00 (0.00%) Volume: 1.57k 5:20 PM EDT Apr 9, 2020
Business Description:
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
Address: 555 Long Wharf Drive, 12th Floor, New Haven, CT, USA, 06511
Telephone: +1 475 238-6837 Website: https://www.bioxceltherapeutics.com
Facsimile: +1 475 238-6837 Email: [email protected]
Details
CEO: Vimal Mehta
Employees: 24 Market Cap: 468.63m
Issue Type: CS
Auditor: BDO USA, LLP
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1720893
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)